CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-01 | Powala Christopher Chief Reg & Develop Officer | Option exercise | +3,400 | 142,843 | ||
| 2019-02-01 | Powala Christopher Chief Reg & Develop Officer | Shares withheld for taxes | −1,114 | $6.96 | $8K | 141,729 |
| 2019-02-01 | Powala Christopher Chief Reg & Develop Officer | Option exercise · Restricted Stock Units | −3,400 | 10,200 | ||
| 2018-12-18 | Powala Christopher Chief Reg & Develop Officer | Option exercise | +1,625 | 139,889 | ||
| 2018-12-18 | Powala Christopher Chief Reg & Develop Officer | Shares withheld for taxes | −446 | $6.30 | $3K | 139,443 |
| 2018-12-18 | Powala Christopher Chief Reg & Develop Officer | Option exercise · Restricted Stock Units | −1,625 | 1,625 | ||
| 2018-12-15 | Powala Christopher Chief Reg & Develop Officer | Option exercise | +1,300 | 138,621 | ||
| 2018-12-15 | Powala Christopher Chief Reg & Develop Officer | Shares withheld for taxes | −357 | $7.31 | $3K | 138,264 |
| 2018-12-15 | Powala Christopher Chief Reg & Develop Officer | Option exercise · Restricted Stock Units | −1,300 | 2,600 | ||
| 2018-05-07 | Powala Christopher Chief Reg & Develop Officer | Option exercise | +5,200 | 138,801 | ||
| 2018-05-07 | Powala Christopher Chief Reg & Develop Officer | Shares withheld for taxes | −1,480 | $18.10 | $27K | 137,321 |
| 2018-05-07 | Powala Christopher Chief Reg & Develop Officer | Option exercise · Restricted Stock Units | −5,200 | 3,900 | ||
| 2018-02-01 | Powala Christopher Chief Reg & Develop Officer | Grant or award · Stock option (right to buy) | +47,600 | 47,600 | ||
| 2018-02-01 | Powala Christopher Chief Reg & Develop Officer | Grant or award · Restricted stock units | +13,600 | 13,600 | ||
| 2017-12-18 | Powala Christopher Chief Operating Officer | Option exercise | +1,625 | 134,095 | ||
| 2017-12-18 | Powala Christopher Chief Operating Officer | Shares withheld for taxes | −494 | $24.12 | $12K | 133,601 |
| 2017-12-18 | Powala Christopher Chief Operating Officer | Option exercise · Restricted Stock Units | −1,625 | 3,250 | ||
| 2017-12-15 | Powala Christopher Chief Operating Officer | Option exercise | +1,300 | 132,865 | ||
| 2017-12-15 | Powala Christopher Chief Operating Officer | Shares withheld for taxes | −395 | $24.23 | $10K | 132,470 |
| 2017-12-15 | Powala Christopher Chief Operating Officer | Option exercise · Restricted Stock Units | −1,300 | 9,100 |
Page 1 of 2 · 27 trades